Alert detail
FDA Approval: COPAXONE (GLATIRAMER ACETATE) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA020622Specialty: Multi-specialtyAdded: 6/26/2026Effective: 1996-12-20billing update
Full alert analysis requires a subscription
Subscribe to access the complete alert summary, AI-generated action recommendations, source document links, LCD revision comparisons, and related alerts.